Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 702

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 702
---
 291 | ​ |                   |                235 | ​ |   |              1,233 | ​ |
| Total comprehensive loss                                                                   | ​ | $                  |            -12,380 | ​ | $ |            -27,741 | ​ | $                 |            -62,953 | ​ | $ |            -84,943 | ​ |

See Notes to Condensed Consolidated Financial Statements.

F- 3

CARA THERAPEUTICS, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (amounts in thousands except share and per share data) (unaudited)

| ​                                                    
 ​                                                    
 ​                                                    
 ​                                                    
 ​                                                    | ​ 
 ​ 
 ​ 
 ​ |            ​ 
            ​ 
            ​ 
 Common Stock 
       Shares | ​ 
 ​ 
 ​ | ​      
 ​      
 ​      
 Amount | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 Additional 
 Paid-In    
 Capital    |       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 ​           
 Accumulated 
 Deficit     |        ​ 
        ​ 
        ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 Accumulated   
 Other         
 Comprehensive 
 Loss          |    ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 ​             
 Total         
 Stockholders’ 
 Equity        |       ​ 
       ​ |
|:-----------------------------------------------------|:--|-------------:|:--|:-------|--:|:--|:-----------|--------:|:--|:------------|---------:|:--|:--------------|-----:|:--|:--------------|--------:|
| Balance at December 31, 2023                         | ​ |    4,540,059 | ​ | $      | 5 | ​ | $          | 742,085 | ​ | $           | -684,745 | ​ | $             | -260 | ​ | $             |  57,085 |
| Stock-based compensation expense                     | ​ |            — | ​ | ​      | — | ​ | ​          |   1,660 | ​ | ​           |        — | ​ | ​             |    — | ​ | ​             |   1,660 |
| Shares issued upon vesting of restricted stock units | ​ |       15,531 | ​ | ​      | — | ​ | ​          |